NCT05185297: HyperFut

Recreational Futsal for Controlled Hypertension

Completed NA Last updated 6 February 2023

What this trial tests

NA trial testing Recreational Futsal in Hypertension,Essential in 40 participants. Completed in 19 December 2022.

Timeline

17 November 2021

Primary endpoint
31 October 2022

19 December 2022

Quick facts

Lead sponsor	University Institute of Maia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	17 November 2021
Primary completion	31 October 2022
Estimated completion	19 December 2022
Sites	1 location across Portugal

Drugs / interventions tested

• Recreational Futsal

Conditions studied

• Hypertension,Essential — all drugs for Hypertension,Essential →
• Hypertension — all drugs for Hypertension →
• Blood Pressure Disorders — all drugs for Blood Pressure Disorders →
• Blood Pressure — all drugs for Blood Pressure →

Sponsor

University Institute of Maia

Who can join

Adults 35 to 60, male only, with Hypertension,Essential or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Arterial hypertension (HT) was the leading global contributor for premature deaths in 2015. Its treatment includes medication and lifestyle changes, namely diet and regular exercise, which has shown to have an inverse relationship with arterial HT.

Recreational soccer (RS) has proven to be a non-pharmacological treatment for several chronic conditions, including arterial HT, with meaningful decreases on blood pressure (BP). Recreation futsal (RF) is expected to elicit comparable BP changes to RS considering that it imposes similar physical and physiological demands.

However, the effects of RF on BP and other cardiovascular markers have not been previously investigated in participants only with controlled arterial HT. Furthermore, acute BP changes and double product elicited by this exercise modality were never described.

Therefore, the main purpose of this study is to assess if RF is an effective coadjuvant intervention for BP control in adults with controlled arterial HT. Secondary purposes are: i) to determine the impact of RF on other cardiovascular markers; ii) to describe the acute BP changes and the double product elicited by RF; and iii) to assess the impact of 1 month of detraining on BP and other cardiovascular markers (4 months).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.